Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preparation time and reconstitution experience with Alluzience versus powder botulinum toxin type A for glabellar lines
2021-004748-62Phase 4Completed
- Sponsor
- Galderma
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of alluzience in glabellar furrowing (2 arms), sponsored by Galderma. Primary endpoint: Time to prepare or reconstitute study product. Started Nov 2021; status: completed.
02
Drugs
alluzience
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on 2021-004748-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004748-62.